Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2005
11/03/2005CA2835840A1 Beneficial effects of increasing local blood flow
11/03/2005CA2798552A1 Poly(lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
11/03/2005CA2564353A1 Galantamine salts, method of producing it and nasal composition thereof
11/03/2005CA2564180A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005CA2564031A1 Method for the purification of albumin conjugates
11/03/2005CA2564019A1 Lozenge for delivery of dextromethorphan
11/03/2005CA2563877A1 Methods and kits for stabilising, protecting and solubilising proteins
11/03/2005CA2563826A1 Treatment of cns disorders using cns target modulators
11/03/2005CA2563744A1 Composition comprising a diuretic and/or cardiac glycoside for the treatment of dna viral infections of the eye
11/03/2005CA2563680A1 Seamless capsule containing water-soluble active substance
11/03/2005CA2563678A1 Beneficial effects of increasing local blood flow
11/03/2005CA2563670A1 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
11/03/2005CA2563665A1 Method of stabilizing disordered cefovecin sodium salt
11/03/2005CA2561553A1 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
11/03/2005CA2559228A1 Bone delivery conjugates and method of using same to target proteins to bone
11/03/2005CA2551643A1 Metal-containing nanolayered composites, and applications thereof
11/02/2005EP1591505A1 Medical non-crosslinked pressure-sensitive adhesive composition, medical adhesive sheet employing the same and, process for producing medical non-crosslinked pressure-sensitive adhesive composition
11/02/2005EP1591467A1 Conjugate between a polyethylene glycol having a terminal alkanal group and a human growth hormone
11/02/2005EP1591453A1 Modified peptides yy and conjugates thereof
11/02/2005EP1591451A1 Peptide conjugate
11/02/2005EP1591450A1 Conjugate for retention in blood and cancer tissue-specific drug delivery
11/02/2005EP1591447A1 Phospholipid derivatives and process for the production there
11/02/2005EP1591125A1 Pharmaceutical composition comprising extracts of lichens and hypericum
11/02/2005EP1591121A1 Steroid hormone products comprising a stabilizing agent in non-crystalline form
11/02/2005EP1591108A2 Solution formulations of sirolimus and its analogs for CAD treatment
11/02/2005EP1591107A1 Process for the selective increase of a release rate of an active material from a pharmaceutical composition
11/02/2005EP1590434A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/02/2005EP1590372A2 Trimeric polypeptide construct to induce an enduring t cell response
11/02/2005EP1590004A2 Improved thickened beverages for dysphagia
11/02/2005EP1589999A2 Polyvinylethers for delivery of polynucleotides to mammalian cells
11/02/2005EP1589981A2 Interferon antagonists useful for the treatment of interferon related diseases
11/02/2005EP1589978A2 Delivery system for functional compounds
11/02/2005EP1589949A1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants
11/02/2005EP1589943A2 Methods of treating lung diseases
11/02/2005EP1589941A1 Composition for preventive treatment of cold sores
11/02/2005EP1589933A2 Compositions and methods for the diagnosis and treatment of tumor
11/02/2005EP1589901A2 Intracutaneous injection
11/02/2005EP1482796A4 Stable compositions comprising tezacitabine
11/02/2005EP1368056B1 Recombinant gelatin-like proteins for use as plasma expanders
11/02/2005EP1357930B1 Histidine-rich glycoprotein (hrgp) for inhibiting angiogenesis
11/02/2005EP1356825B1 Process for producing aqueous cellulose derivative dispersion
11/02/2005EP1307181B1 Novel compositions of minoxidil
11/02/2005EP1296691B1 Use of cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infections
11/02/2005EP1268524B1 Binding peptides for carcinoembryonic antigen (cea)
11/02/2005EP1212039B1 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
11/02/2005EP1200320B1 Valve with a two-component seal
11/02/2005EP1200123B1 Diagnosis and treatment of neuroectodermal tumors
11/02/2005EP1200042B1 Emulsifier-free finely dispersed systems of the oil-in-water type
11/02/2005EP1194133B1 Multilayered film containing an active substance and made of cross-linked hydrophilic polymers
11/02/2005EP1169244B1 Metering valve
11/02/2005EP1162947B1 Potentiation medium
11/02/2005EP1117443B1 Peptide-based carrier devices for stellate cells
11/02/2005EP1097722B1 Excipient
11/02/2005EP1059916B1 Extended release dosage form
11/02/2005CN1691965A Pharmaceutical composition for controlled release and manufacturing method thereof
11/02/2005CN1691942A Dry syrup preparation of procaterol comprising ascorbinic acid and citric acid
11/02/2005CN1691938A Transdermal vaccine delivery device having coated microprotrusions
11/02/2005CN1690079A Polyethylene glycol-modified thymus peptide 1 derivatives
11/02/2005CN1689651A Medical non-crosslinked pressure-sensitive adhesive composition, process for producing medical non-crosslinked pressure-sensitive adhesive composition and medical adhesive sheet
11/02/2005CN1689649A Oral cavity quick dissolving preparation and production method thereof
11/02/2005CN1225287C Stabilized radiopharmaceutical composition
11/02/2005CN1225284C Process for preparing poly lactic acid super microball carrying medicine
11/02/2005CN1225247C Storage stable tretinoin and 4-hydroxy anisole contg. topical compsn.
11/02/2005CN1225242C Erianin fat emulsion as antineoplastic medicine and preparing process thereof
11/02/2005CN1225241C Method for preparing oral disintegrating tablet
11/02/2005CN1225230C High viscosity liquid controlled delivery system
11/01/2005US6960690 Process of making a compound by forming a polymer from a template drug
11/01/2005US6960648 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents
11/01/2005US6960563 Spontaneous emulsions containing cyclosporine
11/01/2005US6960561 Polypeptide mixture containing preservative, surfactant and stabilizer
11/01/2005US6960443 Anticancer, antitumor agents; monoclonal antibodies; genetic engineered protein
11/01/2005US6960431 Inhibiting viral propagation and treating viral infection are provided which include administering to cells infected with viruses a therapeutic peptide or a derivative thereof and peptide associated with a transporter that is capable of
11/01/2005US6960357 Controlled release; drugs mixed with inert ingredients compressed into tablets
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
11/01/2005US6960353 Formulations for the transdermal administration of fenoldopam
11/01/2005US6960352 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent
11/01/2005US6960351 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
11/01/2005US6960346 Using citric acid esters or ethers
11/01/2005US6960344 Use of imine-forming polysaccharides as adjuvants and immunostimulants
11/01/2005US6960341 Bifidobacteria and preparations containing them
11/01/2005US6960300 Process for preparing water soluble diterpenes and their applications
11/01/2005US6960251 Silica comprising at least two silica fractions, wherein said at least two silica fractions differ in value for surface area and oil absorption, in given ranges; good absorbency, low dust
11/01/2005CA2264852C Use of methylphenidate or a pharmaceutically acceptable salt thereof
11/01/2005CA2216371C Novel "burst-free" sustained release poly-(lactide/glycolide) microspheres
10/2005
10/29/2005CA2502992A1 Lubricious germicidal ophthalmic solutions
10/27/2005WO2005100577A1 Method for gene delivery to neuronal cells
10/27/2005WO2005100447A1 Peg-functional nucleic acid conjugate
10/27/2005WO2005100405A2 Phosphorylcholine conjugates and corresponding antibodies
10/27/2005WO2005100404A1 Prostate cancer diagnosis and treatment
10/27/2005WO2005100374A1 Therapeutic heparins and their binding to interleukins 4 and 5, and pecam-1
10/27/2005WO2005100362A1 Liquid external preparation containing pranoprofen
10/27/2005WO2005099889A1 Process for producing hollow nanoparticle with use of liposome as template
10/27/2005WO2005099782A1 Composition comprising intercalated metal-ion sequestrants
10/27/2005WO2005099769A2 Novel g-csf conjugates
10/27/2005WO2005099768A2 Polymeric prodrug with a self-immolative linker
10/27/2005WO2005099767A1 Use of glycerol dipalmitostearate for improving the bioavailability of protein active ingredients in subcutaneous or intramuscular injectable formulations
10/27/2005WO2005099766A1 Crosslinkable pressure-sensitive adhesive for the skin
10/27/2005WO2005099765A1 Liquid composition and process for producing the same
10/27/2005WO2005099764A1 Antifungal composition for external use
10/27/2005WO2005099763A2 Composition for intracellular transfer of a nucleic acid
1 ... 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 ... 1712